AHA Scientific Sessions 2025 Abstract

The effectiveness of the GLP-1 receptors agonists in improving obesity-related heart failure events: A systematic review and meta-analysis of randomized clinical trials.

By Geraldine de Melo, Blas Ivan Ayala, Marina Xavier, Sara Del Vecchio Ziotti

ReviewInterventions

The paper

Geraldine de Melo, Blas Ivan Ayala, Marina Xavier, Sara Del Vecchio Ziotti

Faculdade de Ciências Médicas da Santa Casa de São Paulo; Universidade de São Paulo

AHA Scientific Sessions 2025 Abstract, 3 Nov 2025

Presented at AHA Scientific Sessions 2025, abstract 4353895

doi.org/10.1161/circ.152.suppl_3.4353895

Research Square8 Oct 2026
Semaglutide improved heart artery function in pigs
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial